Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Probir Kumar Ojha

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Hazardous Materials|December 1, 2019
First report on a classification-based QSAR model for chemical toxicity to earthwormJoyita Roy, Probir Kumar Ojha, Edoardo Carnesecchi, et al.
Journal of Computational Chemistry|January 10, 2013
Some case studies on application of "r(m)2" metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response dataKunal Roy, Pratim Chakraborty, Indrani Mitra, et al.
Journal of Chemical Information and Modeling|December 29, 2011
Comparative studies on some metrics for external validation of QSPR modelsKunal Roy, Indrani Mitra, Supratik Kar, et al.
ACS Omega|June 20, 2022
Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> ApproachesShipra Bhatt, Sumit Dhiman, Vinay Kumar, et al.
ACS Omega|April 27, 2022
Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> ApproachesShipra Bhatt, Diksha Manhas, Vinay Kumar, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 4, 2021
Amalgamation of <i>in-silico</i>, <i>in-vitro</i> and <i>in-vivo</i> approach to establish glabridin as a potential CYP2E1 inhibitorShipra Bhatt, Vinay Kumar, Ashish Dogra, et al.
European Journal of Medicinal Chemistry|April 2, 2014
Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part IIHriday Bera, Probir kumar Ojha, Bee Jen Tan, et al.
Cellular Signalling|March 29, 2017
Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and invasionGoutam Dey, Rashmi Bharti, Probir Kumar Ojha, et al.
Molecular Therapy. Nucleic Acids|March 9, 2020
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic HepatocytesSamrat Chakraborty, Zewdu Yilma Dlie, Somdyuti Chakraborty, et al.
Chemico-Biological Interactions|May 5, 2023
Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapyDiksha Manhas, Shipra Bhatt, Garima Rai, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Hazardous Materials|December 1, 2019
First report on a classification-based QSAR model for chemical toxicity to earthwormJoyita Roy, Probir Kumar Ojha, Edoardo Carnesecchi, et al.
Journal of Computational Chemistry|January 10, 2013
Some case studies on application of "r(m)2" metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response dataKunal Roy, Pratim Chakraborty, Indrani Mitra, et al.
Journal of Chemical Information and Modeling|December 29, 2011
Comparative studies on some metrics for external validation of QSPR modelsKunal Roy, Indrani Mitra, Supratik Kar, et al.
ACS Omega|June 20, 2022
Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> ApproachesShipra Bhatt, Sumit Dhiman, Vinay Kumar, et al.
ACS Omega|April 27, 2022
Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> ApproachesShipra Bhatt, Diksha Manhas, Vinay Kumar, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 4, 2021
Amalgamation of <i>in-silico</i>, <i>in-vitro</i> and <i>in-vivo</i> approach to establish glabridin as a potential CYP2E1 inhibitorShipra Bhatt, Vinay Kumar, Ashish Dogra, et al.
European Journal of Medicinal Chemistry|April 2, 2014
Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part IIHriday Bera, Probir kumar Ojha, Bee Jen Tan, et al.
Cellular Signalling|March 29, 2017
Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and invasionGoutam Dey, Rashmi Bharti, Probir Kumar Ojha, et al.
Molecular Therapy. Nucleic Acids|March 9, 2020
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic HepatocytesSamrat Chakraborty, Zewdu Yilma Dlie, Somdyuti Chakraborty, et al.
Chemico-Biological Interactions|May 5, 2023
Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapyDiksha Manhas, Shipra Bhatt, Garima Rai, et al.
Pageof 7